Search Results

Outcomes of malignant tumors of the lacrimal apparatus: the University of Texas MD Anderson Cancer Center experience.

• Authors : Skinner HD; Garden AS; Rosenthal DI

Subjects: CANCER treatment; COMBINED modality therapy; OCULAR tumorsTEXAS

• Source: Cancer (0008543X); 6/15/2011, Vol. 117 Issue 12, p2801-2810, 10p

Record details

Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy.

• Authors : Fang P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .; Pinnix CC

Subjects: Plasmacytoma*/Plasmacytoma*/Plasmacytoma*/pathology ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/diagnosis ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/radiotherapy

• Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 May 01; Vol. 119 (1), pp. 193-199. Date of Electronic Publication: 2023 Dec 08.Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Impact of Demographics and Neighborhood Socioeconomic Variables on Clinical Trial Participation in Non-Hodgkin Lymphoma.

• Authors : Nze C; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Andersen C

• Source: Blood advances [Blood Adv] 2024 Mar 23. Date of Electronic Publication: 2024 Mar 23.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium:

Record details

Empirically Derived Principles for Research Funding Success: A Primer for Early Career Academic Investigators.

• Authors : Wahid KA; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .; Rooney MK

Subjects: Biomedical Research*; Humans ; United States

• Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Mar 01; Vol. 118 (3), pp. 590-594.Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print Cited Medium: Internet ISSN: 1879-355X

Record details

Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma.

• Authors : Steiner RE; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.; Hwang SR

Subjects: Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/therapy; Humans ; Adult

• Source: Blood advances [Blood Adv] 2023 Dec 26; Vol. 7 (24), pp. 7485-7493.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet

Record details

The American Society for Radiation Oncology Workforce Taskforce Review of the United States Radiation Oncology Workforce Analysis.

• Authors : Shah C; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address: .; Mohindra P

Subjects: Radiation Oncology*; Humans ; Aged

• Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Jul 01; Vol. 116 (3), pp. 484-490. Date of Electronic Publication: 2023 Mar 08.Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma.

• Authors : Wu SY; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.; Fang PQ

• Source: Advances in radiation oncology [Adv Radiat Oncol] 2023 Jun 02; Vol. 8 (6), pp. 101279. Date of Electronic Publication: 2023 Jun 02 (Print Publication: 2023).Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101677247 Publication Model: eCollection Cited Medium: Print ISSN:

Record details

Using Holistic Residency Applicant Review and Selection in Radiation Oncology to Enhance Diversity and Inclusion-An ASTRO SCAROP-ADROP-ARRO Collaboration.

• Authors : Jimenez RB; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: .; Pinnix CC

Subjects: Internship and Residency* ; Radiation Oncology*/Radiation Oncology*/Radiation Oncology*/education; Humans

• Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Jun 01; Vol. 116 (2), pp. 334-347. Date of Electronic Publication: 2023 Jan 18.Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma.

• Authors : Afrough A; Department of Stem Cell Transplantation & Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.; Alsfeld LC

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/epidemiology

• Source: Transplantation and cellular therapy [Transplant Cell Ther] 2023 Apr; Vol. 29 (4), pp. 264.e1-264.e9. Date of Electronic Publication: 2022 May 20.Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The American Society for Radiation Oncology Workforce Statement.

• Authors : Shah C; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address: .; Mohindra P

Subjects: Radiation Oncology*/Radiation Oncology*/Radiation Oncology*/education ; Internship and Residency*; Humans

• Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Feb 01; Vol. 115 (2), pp. 281-284. Date of Electronic Publication: 2022 Aug 18.Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details